Rafael Holdings RFL
NYSE RFL
$1.12 +0.05 (+4.67%)
As of: Nov 11, 2026 · 11:01 AM EST

Rafael Holdings (RFL) Shares Outstanding (Diluted) (2017 - 2026)

Updated

Rafael Holdings (RFL) reported Weighted Average Shares Outstanding (Diluted) of 51.39 million for fiscal Q4 2026 (quarter ended Jul 31, 2026), up 74.7% from 29.42 million a year earlier and up 0.3% from the prior quarter.

Analysis

Rafael Holdings (RFL) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends

Dating back to fiscal Q2 2017, Rafael Holdings' Weighted Average Shares Outstanding (Diluted) record includes 39 quarters.

  • Weighted Average Shares Outstanding (Diluted) has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 25.5% (FY2021 to FY2026).
  • By fiscal year, Weighted Average Shares Outstanding (Diluted) came in at 29.42 million in FY2025 (+23.9%), 23.75 million in FY2024 (+2.1%), 23.26 million in FY2023 (+17.7%) and 19.77 million in FY2022 (+19.6%).
  • The fiscal Q4 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q2 2017.
  • Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last six quarters, with growth averaging 54.2% over the last eight quarters.
  • The high point for year-over-year Weighted Average Shares Outstanding (Diluted) in five years was fiscal Q1 2026 (growth of 112.7%); the low point was fiscal Q2 2025 (a decline of 1.0%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at 51.23 million (Q3 2026), 51.23 million (Q2 2026) and 51.18 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Rafael Holdings 55.50 Mn -74.75 Mn 218,000.00 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 51.39 Mn
Apr 30, 2026 51.23 Mn
Jan 31, 2026 51.23 Mn
Oct 31, 2025 51.18 Mn
Jul 31, 2025 29.42 Mn
Apr 30, 2025 25.24 Mn
Jan 31, 2025 24.15 Mn
Oct 31, 2024 24.06 Mn
Jul 31, 2024 23.75 Mn
Apr 30, 2024 23.78 Mn
Jan 31, 2024 24.40 Mn
Oct 31, 2023 23.64 Mn
Jul 31, 2023 23.26 Mn
Apr 30, 2023 23.37 Mn
Jan 31, 2023 23.16 Mn
Oct 31, 2022 23.02 Mn
Jul 31, 2022 19.77 Mn
Apr 30, 2022 19.76 Mn
Jan 31, 2022 19.71 Mn
Oct 31, 2021 18.95 Mn
API Access

Rafael Holdings Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RFL&period=max&api_key=YOUR_API_KEY